It should be emphasized that though hypoadiponectinemia is an important risk factor for metabolic disorders [13,21], adiponectin levels are higher in CKD patients and have been associated with CKD progression [12,16,19,20,21]. Here, ADIPOQ is linked to chronic kidney disease.